Pillstats
Rx only · Aerosol, Metered · Respiratory (Inhalation)

Fluticasone Propionate And Salmeterol Xinafoate

Brands: Advair Hfa · Fluticasone Propionate + Salmeterol Xinafoate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)41126
US makers3 labelers
Packages11
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.86$13.73$20.59$27.45Nov 2025Mar 2026Jul 2026
$23.874
Latest avg · Jul 22, 2026
+19%
Since Nov 19, 2025
3
Active US suppliers
82%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

67K133K200K266K2025 Q12025 Q22025 Q32025 Q42026 Q1
195K
Rx · 2026 Q1
2.5M
Units dispensed
-16%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
GlaxoSmithKline LLCunknown6SUPPLYING
Prasco Laboratoriesunknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 24, 2012
    RECALLRecall (Class III): Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For O…

    Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification. — Recalling firm: GlaxoSmithKline, LLC. — Nationwide and Puerto Rico.

  • Oct 24, 2012
    RECALLRecall (Class III): Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, …

    Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification. — Recalling firm: GlaxoSmithKline, LLC. — Nationwide and Puerto Rico.